Calculation of the plasma drug level with oral controlled release dosage forms. Effect of the dose frequency

International Journal of Pharmaceutics

Volumn 127, Issue 2, 1996, Pages 177-184

  Ouriemchi, E M ^a   Vergnaud, J M ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

Author keywords

calculation; controlled release; dose frequency; in vitro in vivo; multiple dose; plasma drug level

Indexed keywords

ACETYLSALICYLIC ACID; SALICYLATE SODIUM;

ARTICLE; CALCULATION; DIFFUSION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG RELEASE; DRUG TRANSPORT; MATHEMATICS; PRIORITY JOURNAL;

EID: 0029920744     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04125-7     Document Type: Article

References (18)

1. Aquiar, A.J., Wheeler, L.M., Fusari, S. and Zelmer, J.E., Evaluation of physical and pharmaceutical factors involved in drug release and availability from chloramphenicol capsules. J. Pharm. Sci., 57 (1968) 1844-1850.
2. Armand, J.Y., Magnard, F., Bouzon, J., Rollet, M., Taverdet, J.L. and Vergnaud, J.M., Modelling of the release of drug in gastric liquid from spheric galenic forms with Eudragit matrix. Int. J. Pharm., 40 (1987) 33-41.
3. Bidah, D. and Vergnaud, J.M., Kinetics of in vitro release of sodium salicylate dispersed in Gelucire. Int. J. Pharm., 58 (1990) 215-220.
4. Bidah, D., Ouriemchi, E.M. and Vergnaud, J.M., Diffusional process of drug delivery from a dosage form with a Gelucire matrix. Int. J. Pharm., 80 (1992) 145-149.
5. Dominguez-Gil, A., Contribution of biopharmaceutics and pharmacokinetics to improve drug therapy. Eur. J. Drug Metab. Pharmacok., 18 (1993) 1-5.
6. Feijen, J., Controlled drug delivery based on the use of synthetic polymers, 14th Meeting. French Polymer Group, Rouen, Nov. 1984.
7. Hamlin, W.E., Nelson, E., Ballard, B.E. and Wagner, J.G., Loss of sensitivity in distinguishing real differences in dissolution rates due to increasing agitation. J. Pharm. Sci., 51 (1962) 432-435.
8. Heilmann, K., Therapeutic Systems. Georg Thieme, Stuttgart, 1983, pp. 1-33.
9. Heller, J., Biodegradable polymers in controlled drug delivery. CRC Crit. Rev. Therap. Drug Carrier Syst., 1 (1984) 39-90.
10. Levy, G., Comparison of dissolution and absorption rates of different commercial aspirin tablets. J. Pharm. Sci., 52 (1961) 1039-1041.
11. Nelson, E., Solution rate of theophylline salts and effects from oral administration. J. Am. Pharm. Assoc. Sci. Ed, 46 (1957) 607-614.
12. Ouriemchi, E.M., Bouzon, J. and Vergnaud, J.M., Modelling the process of controlled release of drug in in vitro and in vivo tests. Int. J. Pharm., 113 (1995) 231-240.
13. Siewert, M., Perspectives of in vitro dissolution tests in establishing in vivo/in vitro correlations. Eur. J. Drug Metab. Pharmacok., 18 (1993) 7-18.
14. Skelly, J.P. and Shiu, G.F., In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implications. Eur. J. Drug Metab. Pharmacok., 18 (1993) 121-129.
15. Skelly, J.P., Barr, W.H., Benet, L.Z., Doluisio, J.T., Goldberg, A.H., Levy, G.. Lowenthal, D.T., Robinson, J.R., Shah, V.P., Temple, R.J. and Yacobi, A., Report of the workshop on controlled-release dosage forms: issues and controversies. Pharm. Res., 4 (1987) 75-77.
16. Skelly, J.P., Amidon, G.L., Barr, W.H., Benet, L.Z., Carter, J.E., Robinson, J.R., Shah, V.P. and Yacobi, A., In vitro and in vivo testing and correlations for oral controlled/modified release dosage forms. Pharm. Res., 7 (1990) 975-982.
17. Vergnaud, J.M., Controlled Drug Release of Oral Dosage Forms. E. Horwood, Chichester, UK, 1993, pp. 199-259.
18. Vidal, Editions du Vidal, Paris, 1994, pp. 118.